Clinical Trials in Belgium — Country Dashboard | 2,367 EU Studies

Filter these 2,367 trials by condition, phase, sponsor and more.

Open in Search →

2,367 Registered trials

881 Recruiting

1,301 Completed trials

587 Sponsors active

365 Research sites

Phase III

Phase II

Phase III: 1086 Phase II/III: 120 Phase II: 464 Phase I/II: 83 Phase III/IV: 34 Phase IV: 147 Phase I: 145 Phase I (Other): 184 Phase I (FiH): 95 Other: 9

Oversight events in trials active here:

88 serious breaches 545 temporary halts 49 urgent safety measures 56 unexpected events 94 corrective measures across 298 trials

View oversight register →

Top conditions

Non-small cell lung cancer 78 Non-small cell lung cancer metastatic 27 Crohn's disease 27 Ovarian cancer 25 Colorectal cancer 22 Colitis ulcerative 21 Breast cancer 18 Squamous cell carcinoma of head and neck 18 Rheumatoid arthritis 17 Prostate cancer metastatic 17 Fallopian tube cancer 17 HER2 positive breast cancer 17

Top sponsors

Merck Sharp & Dohme LLC 121 Janssen - Cilag International 99 AstraZeneca AB 95 Pfizer Inc. 81 F. Hoffmann-La Roche AG 80 UZ Leuven 72 Novartis Pharma AG 71 Boehringer Ingelheim International GmbH 70 AbbVie Deutschland GmbH & Co. KG 68 Amgen Inc. 49 Sanofi-Aventis Recherche & Developpement 48 Boehringer Ingelheim Espana S.A. 40

Cities with most trials

All 185 cities →

All trials — page 3

2,367 total

A randomized, Phase I, single-center, observer-blind, active-controlled study to evaluate the safety, tolerability and immunogenicity of one… Pending

2024-515972-11-00 Phase I Pneumococcal infection LiteVax B.V.
BEACON 2: A Multi-Arm, Multi-Stage Platform Trial For Relapsed Neuroblastoma Pending

2024-516115-24-00 Phase I/II High risk relapsed neuroblastoma (relapsed or progressed aft… The University Of Birmingham
Multicentric study evaluating the usefulness of early PSMA PET scan in metastatic renal cancer requiring standard immunotherapy treatment. Pending

2024-517098-26-00 Phase II metastatic clear cell Renal Carcinoma Cell Cliniques Universitaires Saint-Luc
Comparison of neurocognitive outcome in two standard regimen for treatment of low-risk medulloblastoma (COGNITO-MB) Pending

2024-517133-40-00 Phase III newly diagnosed, non-metastatic, SHH-activated, TP53-wt, non… GPOH gGmbH
PTX3 genetically stratified randomized double-blinded allocation event-driven clinical trial for antifungal prophylaxis in patients with acu… Pending

2024-517211-79-00 Phase IV Antifungal prophylaxis in patients with acute myeloid leukem… Centre Hospitalier Universitaire Vaudois
A Phase 1/2, First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Anti_Tumor Activity of AVZO-02… Pending

2024-517339-30-00 Phase I (FiH) Advanced Solid Tumors Avenzo Therapeutics Inc.
The effect of corticosteroids on early recovery after major surgery in eldery patients: CORTERAS study Pending

2024-517602-28-00 Phase IV Major surgery: robotic assisted laparoscopic radical prostat… Ziekenhuis Oost Limburg
A Phase III study evaluating the efficacy of atezoliumab administration in addition to BCG (Bacillus Calmette-Guerin) for 1 year in patient… Pending

2024-517621-54-00 Phase III High-risk non-muscle invasive bladder cancer (NMIBC) after t… Unicancer
Efficacy, safety, and tolerability study of lunsekimig compared with placebo in adult participants with inadequately controlled chronic obst… Pending

2024-518016-39-00 Phase II/III Respiratory tract diseases Sanofi-Aventis Recherche & Developpement
Atezolizumab, Pertuzumab and Trastuzumab with chemotherapy as neoadjuvant treatment of HER2 positive early high-risk and locally advanced br… Pending

2024-518026-32-00 Phase III Invasive Breast Cancer Fondazione Michelangelo
LONGITUDINAL FOLLOW-UP OF SARS-COV-2 IMMUNITY IN IMMUNOCOMPROMISED POPULATIONS IN BELGIUM (COVICO) A non-commercial multicenter academic pro… Pending

2024-518098-33-01 Phase IV Healthy persons and immunocompromised patients (nursing home… Sciensano
A phase 2 study of ianalumab in adults with primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) who … Pending

2024-518231-11-00 Phase II Immune thrombocytopenia (ITP) Warm autoimmune hemolytic ane… Novartis Pharma AG
BALLAD Belgium - A trial to evaluate the potential benefit of adjuvant chemotherapy for small bowel adenocarcinoma. The Belgian component of… Pending

2024-518349-85-01 Phase III small bowel adenocarcinoma Groupe Belge D'Oncologie Digestive
EdoxabaN foR IntraCranial Hemorrhage survivors with Atrial Fibrillation Pending

2024-518508-31-00 Phase IV High risk atrial fibrillation patients with previous intracr… Hamilton Health Sciences Corporation; PHRI Population Health Research Institute …
Chemo-immunotherapy before and after surgery for peritoneal metastases of large bowel cancer. Pending

2024-518570-13-00 Phase II/III Resectable peritoneal metastases of a colorectal origin Catharina Ziekenhuis Stichting
The optimal timing of vaccination in pregnancy: a multi-dimensional mechanistic approach to measure immune responses in pregnant women (MATI… Pending

2024-518692-56-00 Phase IV Pregnant University Of Antwerp
Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults with Non-cystic Fibrosis Bronchiectasis (NCFB) Pending

2024-518821-13-00 Phase II Non-cystic Fibrosis Bronchiectasis CSL Behring LLC
Comparison of two treatments (intrathecal baclofen pump and selective dorsal rhizotomy) for children with cerebral palsy who cannot walk Pending

2024-518822-33-01 Phase IV Cerebral Palsy UZ Leuven
REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis. Pending

2024-519298-21-00 Phase III Cancer-Associated Thrombosis (CAT). Regeneron Pharmaceuticals Inc.
Assessing Oxytocin's Role in Mitigating Psychosocial Stress in Breast Cancer Survivors Pending

2024-519383-40-00 Phase III breast cancer UZ Leuven
A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy with Standard-of-Care Combination Regimens … Pending

2024-519504-27-00 Phase III Relapsed Refractory Multiple Myeloma Regeneron Pharmaceuticals Inc.
A clinical trial to learn about the long-term safety of FUB523 (zigakibart) in people with immunoglobulin A (IgA) nephropathy who have compl… Pending

2024-519638-22-00 Phase III IgA nephropathy Novartis Pharma AG
A Phase Ib/II Open-Label, Multicentre Platform Study Evaluating Novel Combinations in Participants with Advanced or Metastatic Non-Small Cel… Pending

2024-519786-22-01 Phase I/II metastatic non-small cell lung cancer (NSCLC) AstraZeneca AB
A trial to learn how well sonesitatug vedotin and capecitabine with or without rilvegostomig work and how safe they are in adults with cance… Pending

2024-519787-40-00 Phase III Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Es… AstraZeneca AB

Showing 49–72 of 2,367 trials

← All countries